Changzhou Qianhong Biopharma Co.,Ltd
- Country
- Ownership
- -
- Established
- 2003-04-30
- Employees
- 900
- Market Cap
- -
- Website
- www.qhsh.com.cn
- Introduction
The company is a leading manufacturer and operator of polysaccharides and protease drugs in the domestic biochemical pharmaceutical industry. It is a national high-tech enterprise and a key key enterprise in the national three pharmaceutical bases. It has won the title of national, provincial and municipal drug quality integrity demonstration enterprise for many years in a row. The company's main business scope: licensing projects: pharmaceutical production; drug contract production; drug wholesale; drug retail; drug import/export (projects requiring approval according to law can only be carried out business activities after approval by relevant departments; specific business projects are subject to approval). The company's main products are two major biochemical drugs, active enzymes and polysaccharides. Corporate honors: advanced units, advanced enterprises, key enterprises, priority grass-roots trade union organizations, model workers' homes, etc.
Clinical Trials
0
Trial Phases
0 Phases
Drug Approvals
58
Drug Approvals
Nadroparin Calcium Injection
- Product Name
- 那屈肝素钙注射液
- Approval Number
- 国药准字H20247012
- Approval Date
- Mar 1, 2024
Heparin Sodium Injection for Lock Flush
- Product Name
- 肝素钠封管注射液
- Approval Number
- 国药准字H20227026
- Approval Date
- Mar 8, 2022
Dalteparin Sodium Injection
- Product Name
- 达肝素钠注射液
- Approval Number
- 国药准字H20153300
- Approval Date
- Nov 9, 2020
Lyophilizing Thrombin Powder
- Product Name
- 凝血酶散
- Approval Number
- 国药准字H32021165
- Approval Date
- Jun 15, 2020
Adenosine Disodium Triphosphate for Injection
- Product Name
- 注射用三磷酸腺苷二钠
- Approval Number
- 国药准字H32022087
- Approval Date
- Jun 15, 2020
Chondroitin Sulfate Injection
- Product Name
- 硫酸软骨素注射液
- Approval Number
- 国药准字H32026363
- Approval Date
- Jun 15, 2020
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- Next